Skip to main content
. 2017 Mar 24;35(15):1730–1736. doi: 10.1200/JCO.2016.71.7579

Fig 2.

Fig 2.

Cumulative incidence of first relapse of acute lymphoblastic leukemia according to (A) taking mercaptopurine (6-MP) with food versus never with food; (B) taking 6-MP with milk or dairy products versus never with milk/dairy; (C) taking 6-MP in the evening/night versus morning/midday versus varying times of day; (D) swallowing 6-MP tablet whole versus crushed/dissolved versus chewed.